Differential effects of interferon-alpha and -beta on the secretion of vascular endothelial growth factor by eutopic and ectopic endometrial stromal cells
Lab / animal
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
Interferon-alpha and -beta differentially regulate vascular endothelial growth factor secretion from eutopic and ectopic endometrial stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Interferon (IFN)-beta, not IFN-alpha, suppresses vascular endothelial growth factor secretion in endometriotic cyst stromal cells. It was suggested that IFN-beta may be more suitable than IFN-alpha as an anti-endometriotic agent.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Antiangiogenic agents are effective inhibitors of endometriosis 2003
- Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis 1998
- Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines 2003
- Use of intraperitoneal interferon alpha-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial 2002
Cited by (3)
- Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis 2004
- Endometriosis: harmful survival of an ectopic tissue 2006
- Interferons: pathogenetic rationale for the treatment of external genital endometriosis and clinical efficacy 2019
References (7)
- Antiangiogenic agents are effective inhibitors of endometriosis via openalex
- Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis via openalex
- Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines via openalex
- Use of intraperitoneal interferon alpha-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial via openalex
- W2042214171 via openalex
- W2128523336 via openalex
- W2135769202 via openalex
Cited by (3)
- Interferons: pathogenetic rationale for the treatment of external genital endometriosis and clinical efficacy 2019
- Endometriosis: harmful survival of an ectopic tissue 2006
- Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis 2004
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:02:42.299833+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK